Agenus Inc AGEN:NASDAQ

Last Price$2.63Cboe Real-Time Last Sale as of 1:03PM ET 1/31/23
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.08(2.94%)
Bid (Size)$2.62 (951)
Ask (Size)$2.63 (1,000)
Day Low / High$2.57 - 2.65
Volume1.1 M

Agenus Enters Clinical Collaborations for Tumor Treatments; Shares Rise

10:55AM ET 5/31/2022 MT Newswires
Agenus (AGEN) said Tuesday it has entered into three clinical collaborations with Targovax, Oxford BioTherapeutics and Immunogenesis to develop treatments for tumors.

The new projects bring the number of collaborations up to six and are related to clinical assets such as botensilimab, balstilimab, zalifrelimab, among others, Agenus said.

The partnerships are with companies that are developing drugs with complementary mechanisms to come up with immunotherapy combinations to treat tumors, the clinical-stage drugmaker said. The studies are sponsored and conducted by the collaborators while Agenus is providing the drugs and scientific support.

The stock was up about 8% in morning trading amid a broadly lower market.

Price: 1.74, Change: +0.13, Percent Change: +7.96